Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

AB0402 PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS

Title: AB0402 PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS
Authors: Yu, K.S.; Kim, B.; Shin, D.; Park, M.K.; Hwang, J.G.; Kim, M.; Chung, H.; Ghim, J.; Chung, J.Y.; Smolen, J.S.; Burmester, G.R.; Kim, S.H.; Bae, Y.; Jeon, D.; Yang, G.; Yoo, J.; Bae, J.; Keystone, E.
Source: Annals of the Rheumatic Diseases ; volume 82, page 1385-1386 ; ISSN 0003-4967
Publisher Information: Elsevier BV
Publication Year: 2023
Collection: ScienceDirect (Elsevier - Open Access Articles via Crossref)
Document Type: article in journal/newspaper
Language: English
DOI: 10.1136/annrheumdis-2023-eular.268
Availability: https://doi.org/10.1136/annrheumdis-2023-eular.268; https://api.elsevier.com/content/article/PII:S0003496724653689?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0003496724653689?httpAccept=text/plain; https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.268
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license
Accession Number: edsbas.A242554
Database: BASE